GSK1358820
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for GSK1358820, covering 2010-01-26 to 2019-10-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity [Phase 3]